Emily M. Leproust sold $257K of Twist Bioscience (TWST)

Executed Feb 3 2025, disclosed Feb 5 2025, 2 days later.

Value, as filed

$257K

5,200 sh × $49.35

Executed

Feb 3 2025

the trade date, as filed

Disclosed

Feb 5 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Emily M. Leproust Chief Executive Officer profile →

Emily M. Leproust (Chief Executive Officer) filed 21 Form 4 reports in the trailing twelve months (0 purchases, 21 sales), most often in Twist Bioscience Corporation (TWST). The largest single filing was $56.3M of TWST (356,546 sh across 13 lots, as filed), executed Sep 17.

The name

TWST

Twist Bioscience Corporation TWST · Healthcare · 110 filings in 24 months ticker →

Healthcare · Twist Bioscience Corporation manufactures and sells synthetic DNA-based products

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Emily M. Leproust in TWST

TWSTSALE Twist Bioscience Corporation $619K
4,573 sh × $135.40
Exec Nov 3
Filed Nov 5 · 4:05 PM ET TWSTSALE Twist Bioscience Corporation $575K
2,857 sh across 2 lots
Exec Oct 5
Filed Oct 7 · 4:05 PM ET TWSTSALE Twist Bioscience Corporation $8.8M
46,391 sh across 2 lots
Exec Oct 1
Filed Oct 5 · 4:05 PM ET TWSTSALE Twist Bioscience Corporation $279K
1,687 sh × $165.49
Exec Sep 21
Filed Sep 23 · 4:07 PM ET TWSTSALE Twist Bioscience Corporation $56.3M
356,546 sh across 13 lots
Exec Sep 17
Filed Sep 21 · 4:05 PM ET TWSTSALE Twist Bioscience Corporation $6.3M
41,570 sh across 5 lots
Exec Aug 25
Filed Aug 27 · 4:05 PM ET TWSTSALE Twist Bioscience Corporation $923K
6,639 sh × $139.07
Exec Aug 21
Filed Aug 25 · 4:05 PM ET TWSTSALE Twist Bioscience Corporation $2.5M
19,952 sh × $125.08
Exec Aug 12
Filed Aug 14 · 4:05 PM ET